Search Results - "Bota, D"

Refine Results
  1. 1

    Deep-Learning Convolutional Neural Networks Accurately Classify Genetic Mutations in Gliomas by Chang, P, Grinband, J, Weinberg, B D, Bardis, M, Khy, M, Cadena, G, Su, M-Y, Cha, S, Filippi, C G, Bota, D, Baldi, P, Poisson, L M, Jain, R, Chow, D

    Published in American journal of neuroradiology : AJNR (01-07-2018)
    “…The World Health Organization has recently placed new emphasis on the integration of genetic information for gliomas. While tissue sampling remains the…”
    Get full text
    Journal Article
  2. 2

    TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth by Di, K, Linskey, M E, Bota, D A

    Published in Oncogene (17-10-2013)
    “…TRIM11 (tripartite motif-containing protein 11), an E3 ubiquitin ligase, is known to be involved in the development of the central nervous system. However,…”
    Get full text
    Journal Article
  3. 3

    Serial Evaluation of the SOFA Score to Predict Outcome in Critically Ill Patients by Ferreira, Flavio Lopes, Bota, Daliana Peres, Bross, Annette, Mélot, Christian, Vincent, Jean-Louis

    “…CONTEXT Evaluation of trends in organ dysfunction in critically ill patients may help predict outcome. OBJECTIVE To determine the usefulness of repeated…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Potential risk factors for infection with Candida spp. in critically ill patients by Peres-Bota, D., Rodriguez-Villalobos, H., Dimopoulos, G., Melot, C., Vincent, J.-L.

    Published in Clinical microbiology and infection (01-06-2004)
    “…The incidence, risk factors and prognostic factors for candidal infection were determined in a prospective study of 280 infected patients. Thirty-one (11%)…”
    Get full text
    Journal Article
  6. 6

    Impairment of Lon-Induced Protection Against the Accumulation of Oxidized Proteins in Senescent Wi-38 Fibroblasts by Ngo, Jenny K., Pomatto, Laura C. D., Bota, Daniela A., Koop, Alison L., Davies, Kelvin J. A.

    “…Oxidative damage to mitochondrial proteins is thought to contribute to the aging process, but the Lon protease normally degrades such proteins. In…”
    Get full text
    Journal Article
  7. 7

    SU‐E‐J‐108: Quantitative Analysis of Longitudinal Cognitive Impairment Due to Radiation Therapy Based on Automatic Segmentation of Hippocampus and Subcortical Structure by Lin, Y, Chang, D, Bota, D, Roa, D, Al‐Ghazi, M, Yu, H, Kuo, J, Nie, K, Fwu, P, Su, M

    Published in Medical Physics (01-06-2012)
    “…Purpose: In this study, we developed a quantitative analysis tool based on patient's longitudinal MR images to 1) measure the radiation dose received by each…”
    Get full text
    Conference Proceeding Journal Article
  8. 8

    Epidemiology and Outcome in Renal Failure by Vincent, J-L., Bota, D. PERES, De Backer, D.

    Published in International journal of artificial organs (01-12-2004)
    “…Acute renal failure (ARF) in the ICU patient usually occurs as part of a wider multiple organ dysfunction, and is associated with mortality rates of around…”
    Get full text
    Book Review Journal Article
  9. 9
  10. 10
  11. 11

    Anemia and Blood Transfusion in Critically Ill Patients by Vincent, Jean Louis, Baron, Jean-François, Reinhart, Konrad, Gattinoni, Luciano, Thijs, Lambert, Webb, Andrew, Meier-Hellmann, Andreas, Nollet, Guy, Peres-Bota, Daliana, for the ABC Investigators

    “…CONTEXT Anemia is a common problem in critically ill patients admitted to intensive care units (ICUs), but the consequences of anemia on morbidity and…”
    Get full text
    Journal Article
  12. 12
  13. 13

    P10.03 Management of low-grade glioma: a systematic review and meta-analysis by Brown, T. J., Bota, D., Maher, E., Aregawi, D., Liau, L. M., Buckner, J., Weller, M., van den Bent, M. J., Berger, M. S., Glantz, M.

    Published in Neuro-oncology (Charlottesville, Va.) (01-05-2017)
    “…Introduction: Low-grade gliomas (LGG, WHO grade I-II) account for 16.9-22% of all primary brain tumors. Management of these tumors consists of surgery,…”
    Get full text
    Journal Article
  14. 14

    OS09.6 Long-term follow-up data from 126 patients with recurrent high grade glioma from three Phase 1 trials of Toca 511 and Toca FC: Update and justification for a Phase 2/3 trial by Aghi, M., Vogelbaum, M. A., Kalkanis, S. N., Bota, D., Piccioni, D., Elder, B., Engh, J., Kaptain, G. J., Landolfi, J., Cloughesy, T. F.

    Published in Neuro-oncology (Charlottesville, Va.) (01-05-2017)
    “…Toca 511 (vocimagene amiretrorepvec) is an investigational, conditionally lytic, retroviral replicating vector. The vector infects human cells with selectivity…”
    Get full text
    Journal Article
  15. 15

    Hepaticojejunostomy without suture by Bratucu, E, Ulmeanu, D, Bota, D

    Published in Digestive surgery (01-01-1998)
    “…Common bile duct (CBD) surgery sometimes demands performing 'a la Roux' hepaticojejunal anastomosis. This kind of stoma is technically easy to perform on a…”
    Get more information
    Journal Article
  16. 16

    RH-01 THE SIGNIFICANCE OF ACUTE INPATIENT REHABILITATION FOR GLIOMA PATIENTS: IMPROVING THE PHYSICAL FUNCTION, QUALITY OF LIFE AND SURVIVAL by Beverly Fu, D., Bota, D. A.

    Published in Neuro-oncology (Charlottesville, Va.) (01-11-2014)
    “…OBJECTIVE: To assess the effects of inpatient acute rehabilitation on overall function, quality of life and overall survival for glioma patients. DESIGN: A…”
    Get full text
    Journal Article
  17. 17
  18. 18

    415OALTERNATING ELECTRIC FIELDS THERAPY FOR RECURRENT GLIOBLASTOMA - NOVOTTF-100A SYSTEM: UPDATED OUTCOMES AND TOXICITY BASED ON THE ANALYSIS OF PATIENT REGISTRY DATA by Mrugala, M.M., Engelhard, H.H., Butowski, N., Tran, D.D., Kew, Y., Cavaliere, R., Villano, J., Bota, D., Kesari, S., Rudnick, J., Sumrall, A., Zhu, J.J., Wong, E.T.

    Published in Annals of oncology (01-09-2014)
    “…Abstract Aim: To present updated outcomes and toxicity data from patients with recurrent glioblastoma treated with the commercially available NovoTTF-100A…”
    Get full text
    Journal Article
  19. 19

    RM-05 CASE OF GLIOBLASTOMA PATIENT TREATED WITH NovoTTF THERAPY AT RECURRENCE DEGENERATING TO SARCOMA by Majd, P., O'Connell, D., Kim, R., Bota, D., Carrillo, J.

    Published in Neuro-oncology (Charlottesville, Va.) (01-11-2014)
    “…NovoTTF treatment is an FDA approved treatment strategy for recurrent Glioblastoma multiforme (GBM) management which employs alternating electric fields to the…”
    Get full text
    Journal Article
  20. 20

    ET-16 MARIZOMIB (NPI-0052) ACTIVITY AS A SINGLE AGENT IN MALIGNANT GLIOMA by Di, K., Gong, X., Nguyen, H., Trikha, M., Bota, D.

    Published in Neuro-oncology (Charlottesville, Va.) (01-11-2014)
    “…Glioblastoma multiforme (GBM) is a highly aggressive brain tumor, which displays innate resistance to multiple treatment modalities. Previous studies have…”
    Get full text
    Journal Article